Publications by authors named "B Mosgaard"
Cancer in pregnancy is rare, and most physicians lack knowledge in handling pregnant cancer patients. This review summarises the present knowledge on this condition. In the Netherlands, an Advisory Board on Cancer in Pregnancy was established in 2012.
View Article and Find Full Text PDFIntroduction: It is debated whether women with FIGO (International Federation of Gynecology and Obstetrics) Stage IV epithelial ovarian cancer should be offered primary debulking surgery (PDS) or interval debulking surgery (IDS). Furthermore, the impact of complete resection of intra-abdominal disease (R0) despite their extra-abdominal metastases is questioned. The objective of this study was to investigate the impact of intra-abdominal residual tumor, Stage IVA vs IVB, the localization and number of metastases defining Stage IV disease on overall survival (OS) comparing PDS and IDS in FIGO Stage IV epithelial ovarian cancer.
View Article and Find Full Text PDFBackground: Treatment for patients with recurrent ovarian cancer has been mainly based on systemic therapy. The role of secondary cytoreductive surgery is unclear.
Methods: We randomly assigned patients with recurrent ovarian cancer who had a first relapse after a platinum-free interval (an interval during which no platinum-based chemotherapy was used) of 6 months or more to undergo secondary cytoreductive surgery and then receive platinum-based chemotherapy or to receive platinum-based chemotherapy alone.
Acute appendicitis is one of the most common causes of acute abdominal pain. Undiagnosed or untreated appendicitis can lead to serious complications. The most frequent complication of acute appendicitis is perforation with subsequent formation of a localized periappendiceal abscess or diffuse bacterial peritonitis.
View Article and Find Full Text PDFArticle Synopsis
- Minimally invasive radical trachelectomy offers a fertility-preserving option for early-stage cervical cancer but has raised concerns about poorer oncologic outcomes compared to open radical hysterectomy.
- A study comparing 4.5-year disease-free survival rates involved 646 patients treated from 2005-2017 across multiple international centers, focusing on those with tumor sizes of ≤2 cm.
- The analysis used Kaplan-Meier methods to evaluate the outcomes, revealing differences in recurrence rates between open and minimally invasive surgical approaches.